Immunotherapeutic approaches in prion disease: progress, challenges and potential directions (vol 4, pg 615, 2013)

被引：0
|
作者：
Brazier, Marcus W.
Mot, Alexandra I.
White, Anthony R.
Collins, Steven J.
机构：
来源：
THERAPEUTIC DELIVERY | 2013年 / 4卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：762 / 762
页数：1
相关论文
共 50 条
  • [21] Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease (vol 500, pg 45, 2013)
    Rhinn, Herve
    NATURE, 2015, 522 (7557) : 429 - 429
  • [22] Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments (vol 41, 449, 2023)
    Dagar, Gunjan
    Gupta, Ashna
    Masoodi, Tariq
    Nisar, Sabah
    Merhi, Maysaloun
    Hashem, Sheema
    Chauhan, Ravi
    Dagar, Manisha
    Mirza, Sameer
    Bagga, Puneet
    Kumar, Rakesh
    Akil, Ammira S. Al-Shabeeb
    Macha, Muzafar A.
    Haris, Mohammad
    Uddin, Shahab
    Singh, Mayank
    Bhat, Ajaz A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [23] The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2–4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches
    Sara M. Melief
    Valeria V. Visconti
    Elien M. Doorduijn
    Saskia J. A. M. Santegoets
    Cancer Immunology, Immunotherapy, 2014, 63 : 1105 - 1112
  • [24] Approaches to Chronic Disease Management Evaluation in Use in Europe: A Review of Current Methods and Performance Measures(vol 29, pg 61, 2013)
    Conklin, Annalijn
    Nolte, Ellen
    Vrijhoef, Hubertus
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (01) : 113 - 113
  • [25] Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease (Retraction of vol 500, pg 45, 2013)
    Rhinn, Herve
    Fujita, Ryousuke
    Qiang, Liang
    Chen, Rong
    Lee, Joseph H.
    Abeliovich, Asa
    NATURE, 2015, 523 (7562)
  • [26] The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2-4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches
    Melief, Sara M.
    Visconti, Valeria V.
    Doorduijn, Elien M.
    Santegoets, Saskia J. A. M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (10) : 1105 - 1112
  • [27] RETRACTION: Novel 2-Aminobenzamides as Potential Orally Active Antithrombotic Agents (Retraction of Vol 4, Pg 32, 2013)
    Verma, Amit
    Giridhar, Rajani
    Kanhed, Ashish
    Sinha, Anshuman
    Modh, Pratik
    Yadav, Mange R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (02): : 226 - 226
  • [28] 4-Alkyloxyimino-Cytosine Nucleotides: Tethering Approaches to Molecular Probes for the P2Y6 Receptor (vol 4, pg 1156, 2013)
    Jayasekara, P. Suresh
    Barrett, Matthew O.
    Ball, Christopher B.
    Brown, Kyle A.
    Kozma, Eszter
    Costanzi, Stefano
    Squarcialupi, Lucia
    Balasubramanian, Ramachandran
    Maruokaa, Hiroshi
    Jacobson, Kenneth A.
    MEDCHEMCOMM, 2013, 4 (12) : 1624 - 1624
  • [29] Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls (vol 64, pg S555, 2018)
    Sigurdsson, Einar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (02) : 855 - 856
  • [30] Targeting tumor cell resistance to apoptosis induction with antisense oligo nucleotides: progress and therapeutic potential (vol 4, pg 9, 2001)
    Olie, RA
    Langemeister-Wittke, U
    DRUG RESISTANCE UPDATES, 2001, 4 (02) : 139 - 139
12345